Thermo Fisher Scientific Inc (TMO) exhibits 41.0% gross margins and 9.3% return on invested capital within Industrials (Industrial Machinery/Components), balanced against a 30.4x enterprise multiple and 6.7% implied options volatility.
Sustained 41.0% gross profitability converts into 17.4% operating margin and 9.3% ROIC, outpacing sector cost of capital.
ROIC: 9.3% // GM: 41.0%YoY revenue trajectory of +3.9% paired with 2.40% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +3.9% // FCF YLD: 2.40%Altman Z-Score of 4.50 and Piotroski F-Score of 8/9 indicate low near-term refinancing stress.
ALTMAN Z: 4.50 // F-SCORE: 8/9Trading at 39.0x trailing P/E (36.3x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 39.0x // EV/EBITDA: 30.4xOptions market prices a ±6.7% implied move with a 0.68 put/call ratio around $695.00 max pain.
IMPL MOVE: ±6.7% // P/C: 0.68Elevated industry capital intensity and customer concentration in Industrial Machinery/Components require continuous execution to defend 15.1% net margins.
NET MARGIN: 15.1% // D/E: 0.42x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for TMO & activate live FRED threshold breach alerts.